LICITRA, LISA FRANCESCA LINDA
LICITRA, LISA FRANCESCA LINDA
Dipartimento di Oncologia ed Emato-Oncologia
INDUCE-3: A Randomized Phase II/III Study of First-line Feladilimab plus Pembrolizumab in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
2026 D. Rischin, A. R Hansen, E.E. W Cohen, M. Tahara, K. J Harrington, R. I Haddad, L. Licitra, H. Mehanna, R. L Ferris, P. Koralewski
Personalized treatment in HPV+ oropharynx cancer using genomic adjusted radiation dose
2025 E. Ho, L. De Cecco, S.A. Eschrich, S. Cavalieri, G. Sedor, F. Hoebers, R.H. Brakenhoff, K. Scheckenbach, T. Poli, K. Yang, J.A. Scarborough, S. Nellore, S. Campbell, N. Woody, T. Chan, J. Miller, N. Silver, S. Koyfman, J. Bates, J.J. Caudell, M.W. Kattan, L. Licitra, J.F. Torres-Roca, J.G. Scott
Xevinapant or Placebo Plus Platinum-Based Chemoradiotherapy in Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck (TrilynX): A Randomized, Phase III Study
2025 J. Bourhis, L. Licitra, B. Burtness, A. Psyrri, R. Haddad, K. Harrington, E.E.W. Cohen, J.D. Schoenfeld
Buparlisib and Paclitaxel in Patients with Head and Neck Squamous Cell Carcinoma: Immunogenomic Biomarkers of Efficacy from the BERIL-1 Study
2025 A. Desilets, J. Lucas, L.F. Licitra, S. Lu, A. Tse, T. Tang, K. Dreyer, N. He, L.E. Birgerson, S. Faivre, D. Soulières
International consensus on laryngeal preservation strategies in laryngeal and hypopharyngeal canonccer
2025 M. Ferrari, F. Mularoni, D. Smussi, P. Gaudioso, P. Bonomo, J. Friborg, M.G. Ghi, V. Gregoire, K. Harrington, K. Hunter, R. Maroldi, R. Martino, R. Mesia, G. Peretti, A. Psyrri, A. Schindler, G. Succo, P. Szturz, I. Vilaseca, P. Nicolai, P. Bossi, J.P. Agarwal, M. Ansarin, A. Argiris, P. Balermpas, N.M.L. Battisti, E. Bellini, A. Bertolin, A.L.C. Carobbio, C.M. Chiesa-Estomba, B. Cirauqui, E. Crosetti, T.B. De Oliveira, A. Deganello, A. Dietz, J.G. Eriksen, A. Eskander, N. Fakhry, A. Falco, D. Farina, R. Ferrarotto, C. Franzese, S. Ghosh Laskar, W. Golusinski, E.Y. Hanna, J.C. Irish, N. Kiyota, L.P. Kowalski, S. Krishnan, N. Lee, C.R. Leemans, L. Licitra, L.D. Locati, J.-. Machiels, F. Marchi, D. Mattavelli, H. Mehanna, G. Mercante, N. Montalto, P. Morbini, B. O'Sullivan, M. Oliva, E. Orlandi, A. Paderno, V. Paleri, F. Pameijer, F. Perri, R. Persio, C. Piazza, Y. Pointreau, L. Presutti, M. Ravanelli, D. Rischin, J.P. Rodrigo, A. Ruaro, G. Sanguineti, C. Simon, L. Siu, A. Spreafico, G. Spriano, S. Taboni, U. Tassini, S. Tribius, M. Van Den Brekel, V. Vander Poorten, D. Viros Porcuna
Impact of molecular tests and precision oncology on patients with advanced thyroid carcinomas in a referral center: the OrienTHYring real-world study
2025 E. Colombo, S. Cavalieri, A. Vingiani, L. Agnelli, M. Duca, B. Paolini, F. Perrone, E. Tamborini, I. Capone, A. Piccolo, F. Caspani, C. Bergamini, S. Alfieri, C. Resteghini, I. Nuzzolese, A. Ottini, S. Buriolla, M. Salvetti, G. Calareso, M. Milione, G. Pruneri, L.D. Locati, L. Licitra
Sinonasal malignancy: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up ☆
2025 C. Resteghini, B. Baujat, P. Bossi, A. Franchi, L. De Gabory, J. Halamkova, F. Haubner, J.A.U. Hardillo, M.A. Hermsen, N.A. Iacovelli, R. Maroldi, S. Mattheis, A. Moya-Plana, P. Nicolai, E. Orlandi, J. Thariat, A. Trama, M.W.M. Van Den Brekel, C.M.L. Van Herpen, B. Verillaud, E. Kinloch, L. Licitra, C. Even
Epithelial head and neck cancer survival in Europe: Geographical variation, time trends and long term survival
2025 G. Gatta, S. Luttmann, A. Trama, S. Rossi, J. Galceran, K. Innos, M. Guevara, L. Licitra, D. Bennet, D. Redondo-Sanchez, R. Capocaccia
Impact of head and neck cancer on the income of Italian employees
2025 A. Macciotta, A. Trama, A. Bernasconi, L. Licitra, R. Leombruni, M. Malisan, F. Ricceri, N. Zengarini, E. Farina
Sinonasal Sarcomas Management: An International Consensus Statement
2025 A. Vinciguerra, F. Caspani, M. Valentini, A.M. Camarda, S. Provenzano, E.W. Wang, C. Meco, M. Ferrari, P. Surda, S. Harrabi, F.A.B. Campos, J.M. Broto, B.A. Guadagnolo, P. Navarria, A. Hosni, N. Hindi, A. Italiano, D.M. Trifiletti, B. Kasper, B. Verillaud, A. Schreiber, P. Castelnuovo, P. Nicolai, I. Dallan, M. Chacon, S.Y. Su, J. Thariat, C. Valverde, M. Lechner, J.Y. Blay, M.R. Fiore, J.A. Eloy, M. Brahmi, J.N. Palmer, V.C. Oliden, D. Greto, I. Lugowska, A.P.D. Tos, T. Van Zele, A.J. Psaltis, P.G. Casali, A. Dufresne, C. Sangalli, C. Georgalas, E. Orlandi, P.-. Wormald, P. Herman, R. Carrau, E.Y. Hanna, L. Licitra, M. Turri-Zanoni, P. Battaglia
Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide in head and neck cancer: the CONFRONT phase I-II trial
2025 M.C. Merlano, N. Denaro, M. Paccagnella, A. Abbona, D. Galizia, S. Alfieri, C. Bergamini, E. Orlandi, A.M. Merlotti, S. Bondi, L. Licitra, O. Garrone
Mutational Landscape of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Association with Immune Checkpoint Inhibitor Outcomes
2025 P. Mccoon, Y. Wang, Z. Lai, Q. Zhang, W. Li, S. Wildsmith, N. Morsli, R. Raja, N. Holoweckyj, J. Walker, M. De Los Reyes, R. Mesia, L. Licitra, R.L. Ferris, J. Fayette, D.P. Zandberg, L.L. Siu, R. Haddad
Randomized clinical efficacy and safety study of peltopepimut-S plus cemiplimab compared to cemiplimab alone in patients with recurrent/metastatic HPV16-positive head and neck cancer
2025 C. Even, K.J. Harrington, E. Massarelli, S. Laban, J. Fayette, M. Oliva, M. Klein Hesselink, S. Visscher, M.G. Fury, A.-. Wiekmeijer, L. Licitra, B. Melichar, L.A. Devriese, I. Brana, P. Jankowska, M. Posner, B. Glisson, A. Kong, L. Hooftman, C.J.M. Melief, R. Ferrarotto
INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
2025 J. Fayette, L. Licitra, K. Harrington, R. Haddad, L.L. Siu, Y.-. Liu, M. Tahara, J.-. Machiels, D. Rischin, T.Y. Seiwert, R.L. Ferris, U. Keilholz, A. Psyrri, B. Keam, P. Bossi, R. Metcalf, C.-. Hsieh, P.M.J. Clement, P. Isaev, A. Mudunov, J. Dinis, A. Hoeben, S. Kasper, K. Klinghammer, M. Hwang, J. Blando, O. Serrano, D. Ruscica, R.B. Cohen
Treatment-related mortality in head and neck cancer patients receiving chemotherapy and radiation: results of a meta-analysis of published trials
2025 C. Gurizzan, M. Cinquini, L. Legramandi, C. Resteghini, M. Siano, C. Bergamini, L. Lorini, D. Smussi, A. Paderno, L. Licitra, P. Bossi
The role of volumetry in sinonasal cancer response assessment to induction chemotherapy, results from two phase II non-randomized controlled prospective multicentric trials: SINTART-1 and SINTART-2
2025 P. Rondi, D. Mattavelli, V. Rampinelli, A. Schreiber, E. Orlandi, B. Vischioni, N.A. Iacovelli, G. Calareso, C. Bergamini, S. Alfieri, P. Castelnuovo, P. Battaglia, M. Turri-Zanoni, P. Nicolai, M. Ferrari, L. Licitra, P. Bossi, D. Farina, M. Ravanelli, C. Resteghini
Clonality, Virulence Genes, and Antimicrobial Resistance of Dairy Ruminants in Mastitic Milk-Associated Staphylococcus aureus in Sicily
2025 N. Russo, N. Alberto Fazio, F. Licitra, J. Gajewska, A. Stamilla, R. Salonia, W. Chajęcka-Wierzchowska, C.L. Randazzo, C. Caggia, F. Antoci, G. Cascone
Lenvatinib in advanced thyroid, salivary gland, endometrial, and hepatocellular carcinomas: a real-world study on treatment duration and toxicity management
2025 E. Colombo, M. Ducceschi, S. Cavalieri, M. Polignano, M. Bini, P. Ambrosini, M. De Monte, G. Montelatici, A. Russo, V. Bellia, S. Bhoori, C. Bergamini, S. Alfieri, I. Nuzzolese, A. Ottini, V. Mazzaferro, F. Raspagliesi, L. Licitra, M. Mantiero
Development, Validation, and Valuation of a Head and Neck Cancer-Specific Health Utility Instrument (HNC-8D): A Head and Neck Cancer International Group Collaborative Study
2025 J.R. De Almeida, J. Su, A. Alshenaiber, H. Noroozi, M. Buttner, D.P. Goldstein, A. Hansen, L.P. Kowalski, L. Licitra, H. Mehanna, C.W. Noel, A. Parmar, S. Porceddu, J. Ringash, S. Rogers, M.A. Dos Santos, C. Simon, M.-. Truong, W. Xu
Treatment decision-making factors and sequencing in recurrent and/or metastatic squamous cell carcinoma of the head and neck
2025 P. Szturz, T. Fuereder, Y. Guo, L. Licitra, R. Mesia, P. Ivanyi, A. Falco, M. Tahara, M.-. Solbes, F. Venturini, P. Bossi